Abstract | BACKGROUND: METHODS: Three populations were studied: syncope patients, epilepsy patients and controls. Vasovagal syncope diagnosis was ascertained with the Calgary Syncope Score and epilepsy diagnosis was confirmed with EEG. Plasma levels of endothelin-1 were measured using by ELISA and copeptin levels were determined using an EIA kit. RESULTS: Asymptomatic control subjects had mean age 35 ± 11 years (7/22 male); epileptic subjects had mean age 32 ± 7 years (4/15 male); and syncope subjects had mean age 33 ± 16 years (4 of 21 male). Circulating plasma levels of endothelin-1 and copeptin were no different among the three groups. Mean concentrations of endothelin-1 were as follows: syncope, 23 ± 32 pg/mL; controls, 21 ± 17 pg/mL; and epileptics, 18 ± 12 pg/mL. Mean concentrations of copeptin were as follows: syncope, 1·29 ± 0·79 ng/mL; controls, 1·25 ± 0·79 ng/mL; and seizures, 1·23 ± 0·45 ng/mL. There were no significant correlations between syncope frequency and copeptin or endothelin-1 levels. CONCLUSION: Circulating plasma endothelin-1 and copeptin levels are not significantly different among populations of controls, syncope patients and seizure patients.
|
Authors | Arjun Rash, Maureen McRae, Jaleh Fatehi, Deborah Richie, Monica Solbiati, Neelan Pillay, Annegret Ulke-Lemée, Justin MacDonald, Robert Sheldon |
Journal | European journal of clinical investigation
(Eur J Clin Invest)
Vol. 46
Issue 2
Pg. 141-5
(Feb 2016)
ISSN: 1365-2362 [Electronic] England |
PMID | 26641207
(Publication Type: Journal Article)
|
Copyright | © 2015 Stichting European Society for Clinical Investigation Journal Foundation. |
Chemical References |
- Biomarkers
- Endothelin-1
- Glycopeptides
- copeptins
|
Topics |
- Adult
- Biomarkers
(blood)
- Case-Control Studies
- Endothelin-1
(blood)
- Enzyme-Linked Immunosorbent Assay
- Epilepsy
(blood)
- Female
- Glycopeptides
(blood)
- Humans
- Immunoenzyme Techniques
- Male
- Middle Aged
- Syncope, Vasovagal
(blood)
- Young Adult
|